163 related articles for article (PubMed ID: 26836258)
1. Amorphous Protic Ionic Systems as Promising Active Pharmaceutical Ingredients: The Case of the Sumatriptan Succinate Drug.
Wojnarowska Z; Knapik J; Rams-Baron M; Jedrzejowska A; Paczkowska M; Krause A; Cielecka-Piontek J; Jaworska M; Lodowski P; Paluch M
Mol Pharm; 2016 Mar; 13(3):1111-22. PubMed ID: 26836258
[TBL] [Abstract][Full Text] [Related]
2. Decoupling of conductivity relaxation from structural relaxation in protic ionic liquids and general properties.
Wojnarowska Z; Kołodziejczyk K; Paluch KJ; Tajber L; Grzybowska K; Ngai KL; Paluch M
Phys Chem Chem Phys; 2013 Jun; 15(23):9205-11. PubMed ID: 23652993
[TBL] [Abstract][Full Text] [Related]
3. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
[TBL] [Abstract][Full Text] [Related]
4. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
5. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
[TBL] [Abstract][Full Text] [Related]
6. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
7. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.
Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640
[TBL] [Abstract][Full Text] [Related]
9. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
10. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
[TBL] [Abstract][Full Text] [Related]
11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics studies on the water mixtures of pharmaceutically important ionic liquid lidocaine HCl.
Wojnarowska Z; Grzybowska K; Hawelek L; Swiety-Pospiech A; Masiewicz E; Paluch M; Sawicki W; Chmielewska A; Bujak P; Markowski J
Mol Pharm; 2012 May; 9(5):1250-61. PubMed ID: 22424553
[TBL] [Abstract][Full Text] [Related]
13. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of amorphous paracetamol based systems using traditional and novel strategies.
Martínez LM; Videa M; López-Silva GA; de Los Reyes CA; Cruz-Angeles J; González N
Int J Pharm; 2014 Dec; 477(1-2):294-305. PubMed ID: 25447825
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Physical Stability of Amorphous Tenapanor Hydrochloride Using Local Molecular Structure Analysis, Relaxation Time Constants, and Molecular Modeling.
Kothari S; Vippagunta RR
Mol Pharm; 2019 Mar; 16(3):943-951. PubMed ID: 30699296
[TBL] [Abstract][Full Text] [Related]
16. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
17. Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
Kaminska E; Tarnacka M; Wlodarczyk P; Jurkiewicz K; Kolodziejczyk K; Dulski M; Haznar-Garbacz D; Hawelek L; Kaminski K; Wlodarczyk A; Paluch M
Mol Pharm; 2015 Aug; 12(8):3007-19. PubMed ID: 26101945
[TBL] [Abstract][Full Text] [Related]
18. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
19. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
Sibik J; Löbmann K; Rades T; Zeitler JA
Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
[TBL] [Abstract][Full Text] [Related]
20. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
